Intended for healthcare professionals

Letters Dangers of selective NSAIDs

Selective COX-2 inhibitors are safe and effective

BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m311 (Published 28 January 2020) Cite this as: BMJ 2020;368:m311
  1. Ian L P Beales, consultant gastroenterologist
  1. Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK
  1. i.beales{at}uea.ac.uk

I am disappointed that The BMJ published a poorly referenced letter on the dangers of selective non-steroidal anti-inflammatory drug (NSAID) prescribing in the Quality and Outcomes Framework.1 The guidance advocating prescription of selective COX-2 inhibitors for patients at high risk of gastrointestinal complications is correct and evidence based.234 To follow another path and use a …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription